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Background & Objectives: Clostridium difficile is gram-positive rod, spore forming, strict 
anaerobic bacillus and the major cause of nosocomial diarrhea. C.difficile is responsible for a 
spectrum of C.difficile infection (CDI) that can be ranged from mild, self-limiting diarrhea to 
a severe colitis, perforation of colon, pseudomembranous colitis or toxic megacolon and 
death.The aim of this study was to investigate the antimicrobial susceptibility patterns of 
C.difficile clinical isolates against antibiotics commonly used for treatment of CDIin 
hospitalized patients. 
Methods: During a 12 month study, 75 C.difficile isolates were collected from 390 patients 
with CDI. All samples were treated with alcohol and yeast extract broth. The treated 
suspensions were cultured on a selective cycloserine cefoxitin fructose agar (CCFA) 
supplemented with 5% sheep blood and incubated in anaerobic conditions, at 37 °C for 5 
days. In vitro susceptibility of   the clinical isolates to 5 antimicrobial agents, including 
metronidazole, vancomycin, clindamycin, erythromycin and cefotaxime were investigated by 
agar dilution Methods, according to the CLSI guideline. 
Results: Metronidazole and vancomycin had good activity against C.difficile isolates with 
MIC90 of 2 and 1 µg/ml, respectively. Seventy one (94.6%) of the isolates were inhibited by 
concentrations that did not exceed 2 µg/ml for metronidazole. Resistant to metronidazole 
observed in 5.3% of the isolates. Out of 43 resistant isolates to erythromycin, 9 (12%) isolates 
had high-level MIC of more than 64 µg/ml. All strains were resistant to cefotaxime (100%). 
Sixty seven (89.3%) isolates were resistant to clindamycin (MIC90s>256 µg/ml) and only 
6.7% were sensitive to clindamycin. 
Conclusion: According to our findings, cefotaxim, clindamycin, erythromycin are not 
effective drugs for treatment of CDI. Although resistant to metronidazole has seen among our 
isolates but it seems that metronidazole and vancomycin can be effective drugs for treatment 
of CDI. 
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